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This study investigates three questions related to medical practice variation. First, it tests 
whether average length of stay across Portuguese National Health Service hospitals varies 
when controlling for differences in patients’ characteristics. Second, it looks at hospital-level 
characteristics in order to find out whether these are able to explain differences in average 
length of stay across hospitals. Finally, it proposes a best practice average length of stay for 
each of the six episodes of care analyzed. To perform the analysis, administrative data from 
the Diagnosis-Related groups’ data set for the year of 2012 was used. A replication of a 
hierarchical two-stage model with hospital fixed effects was carried out. The results show that 
after taking patients’ characteristics into account, variation in average length of stay across 
hospitals exists. This variation cannot be explained by hospital-level characteristics.  
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Medical practice variation means that there are different procedures, which can be chosen to 
treat the same medical condition. Consequently, the choice of the treatment and the duration 
of hospital stay will depend on many factors such as the patient’s needs and illness, the 
information that is available to the physician, the availability of resources, among others. The 
literature has documented that wide variations across hospitals and geographical areas exist. 
However, Smits (1986, p.92) identified three cases in which practice variation is not 
problematic, namely “when uncertainties in the science of medicine lead to acceptable 
alternate practice patterns; when an innovation in diagnostic or treatment modality is in a 
phase of active dissemination; and where the variation reflects underlying differences in the 
population’s health status”. If concluded that the patients’ characteristics and treatment-
related factors explain variation in length of stay (LoS), this variation will be regarded as 
acceptable. However, if these sources do not explain variation across providers, practice 
variation can be related to inefficiency. Therefore, in order to be cautious whilst drawing 
conclusions about inefficiency across hospitals, in a first step, patient-level variables need to 
be taken into account when analyzing variation.  
This study is concerned with three questions related to variation in medical practice. First, 
does the average length of stay across Portuguese National Health Service (NHS) hospitals 
vary much when adjusting for patients’ case mix? Second, what explains these differences in 
average length of stay? Third, what would be the average length of stay if all hospitals would 
have an average length of stay equal to that of the benchmark hospitals? The study will focus 
on the year of 2012 and on six medical conditions using administrative data from hospital 
episodes in Portugal. 
To carry out the analysis a replication of a regression model was performed, using a 
hierarchical, two-stage model with hospital fixed effects (Street, Conrad, Thomas, & Josselin, 
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2012). In the first stage, the models predict hospital length of stay as a function of Diagnosis-
Related Groups’ (DRG) dummy variables, patients’ characteristics and treatment-specific 
variables. For each medical condition a graph with the average hospital fixed effects is 
provided. These graphs report the average hospital effects of each hospital compared to the 
national average by taking into account the influence of the variables included in the first 
stage. In the second stage, the estimated hospital fixed effects are regressed against a set of 
hospital characteristics in order to find out if these can explain differences in average length 
of stay across hospitals. 
The results show that a large part of the variation in average length of stay is not due to the 
fact that different hospitals serve different populations. The study indicates that, after 
adjusting for patient-level variables, some hospitals exhibit an average length of stay that is 
around 20% to 50% below or above the national average length of stay. With just one 
exception (appendectomy), hospital characteristics do not account for this variation. These 
findings are in line with previous studies.
1
 The unexplained variation may be related to 
hospitals’ inefficiency, physicians’ practice or hospitals’ policies as well as to patients’ 
characteristics, which were not included in the models. The results suggest that there is room 
for hospitals to improve efficiency. If all hospitals were able to meet the standards of the 
benchmark hospitals, a decrease in average length of stay would be possible and more 
patients could be treated. 
The study is organized as follows. Section 2 provides a literature review on the topic. Section 
3 justifies the choice of the medical conditions analyzed, designated as “episodes of care”. 
Section 4 presents the data set and explains the methodological approach as well as the 
variables’ choice. Section 5 discusses the results and Section 6 draws the main conclusions of 
the study. 
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2. Literature Review 
The literature on medical practice variation includes analyzing mainly variation in hospital 
admissions and readmissions, length of stay, the frequency of procedures as well as variation 
in the supply of health care resources per capita (Corallo, et al., 2014). The creation of the 
Dartmouth research group, which documented that there is “no standard of practice 
throughout the United States” (Wennberg, 2008, p. 10), has increased research in this area.  
The authors, who analyzed practice variation, agree that there is variation across providers or 
geographical areas. However, the conclusions about the causes of variation are diverse. The 
amount of variation explained by some factors is also debatable and subject to the method 
used. Bernstein, Reschovsky and White (2011, p.3-4) noticed that “as research methods have 
improved, less geographic variation in health care appears to be unexplained” and that 
“geographical variation is extremely sensitive to how comprehensively health status is 
measured”. By comparing some studies, these authors reported that the study with less 
indicators explained 18% of geographic spending variation, whereas the one which included 
many measures found that health status explained about 30% of variation. 
Lu et al. (2015, p. 362) concluded that the literature incorporates many determinants that 
affect hospital length of stay such as “patient characteristics; hospital characteristics; clinical 
caregiver characteristics; and social/family environment characteristics”. However, the 
authors draw attention to the fact that many studies are able to explain roughly 50% of length 
of stay variation when they just control patient characteristics (Lu, Sajobi, Lucyk, Cameron, 
& Quan, 2015).  
Besides the commonly used demographic variables (namely age and gender) some studies 
introduced disease groupers and/or comorbidity indexes as risk adjustors to test for their 
ability to explain LoS (Lu, Sajobi, Lucyk, Cameron, & Quan, 2015). The most frequently 
used disease grouper and comorbidity index is the Diagnosis-related Group and the Charlson 
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index, respectively. These are also the ones that perform best (Lu, Sajobi, Lucyk, Cameron, & 




Regarding hospital characteristics, previous studies have focused much of their attention on 
ownership status. For instance, Siciliani et al. (2011, p. 234) concluded that private and public 
treatment centers “have on average respectively 40% and 18% shorter length of stay 
compared to NHS public hospitals, even after controlling for differences in age, gender, 
number and type of diagnosis, deprivation and geographical variation”. In this case, these 
differences were interpreted “as due to efficiency as opposed to selection (treatment of less 
complex cases)” (Siciliani, Sivey, & Street, 2013, p. 234).  
Using duration of hospital stay as a measure of variations in hospital medical practice, 
Westert, Nieboer and Groenewegen (1993) came to the conclusion that variation in length of 
stay within hospitals was smaller than the length of stay variation between different hospitals. 
This means that “doctors conform to local standards with regard to length of stay decisions” 
(Westert, Nieboer, & Groenewegen, 1993, p. 838). Jong et al. (2006, p. 374) did a similar 
analysis by testing and confirming “the hypothesis that physicians who work in different 
hospitals adapt their length of stay decisions to what is usual in the hospital under 
consideration”. 
Moreover, an important and common feature found is that variation in length of stay remains 
unexplained after controlling for one or more of the following factors: demographic factors, 
patient characteristics, hospital characteristics, risk factors, diagnosis and procedures. For 
instance, a study found that “59% of the overall variation in length of stay remained 
unexplained after adjustment for discharge-level disease status, illness-severity, regional 
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poverty, hospital-level contextual factors”, whereas “77% of the explainable variation was 
due to differences between hospitals” (Walsh, Onega, & Mackenzie, 2014, p. 53). By looking 
at different procedures, another study by Gaughan, Mason et al. (2012) concluded that 
patients’ characteristics, treatment-specific variables, the Charlson comorbidity index and the 
Healthcare Resource Groups
3
 explained between 28% and 63% of variation in length of stay. 
Interestingly, both this study and the articles of the second phase of the EuroDRG project 
found that hospital characteristics, in almost every episode of care analysed, were not able to 
explain variation in LoS across hospitals when taking patients’ characteristics into account.  
The admission method and discharge destination seem also relevant when explaining LoS 
(Gaughan, Mason, Street, & Ward, 2012; Kulinskaya, Kornbrot, & Gao, 2005). One study 
came to the conclusion that “LoS is at least 25% longer for patients transferred from other 
hospitals rather than admitted as an emergency; and LoS for patients discharged to private 
institutions is more than twice that for patients discharged to NHS institutions or their own 
home” (Kulinskaya, Kornbrot, & Gao, 2005, p. 369). 
Finally, according to Corallo, Ashley et al. (2014), the medical conditions studied most 
intensively when analyzing practice variation are cancer, cardiovascular, gynecological, 
musculoskeletal, and respiratory conditions. Regarding the studies, which look at surgical 
conditions, the focus is on cardiovascular surgeries and cancer surgeries. 
First, this study will test whether (1) patient-level characteristics can explain variation in 
length of stay; (2) differences in average length of stay across hospitals exist when differences 
in the patients’ population are taken into account; (3) a set of hospital characteristics is able to 
explain differences in average length of stay across hospitals. Second, it is interesting to look 
for a best practice length of stay for each medical condition studied, since the literature does 
not focus on this aspect, although it seems relevant at least for the Portuguese case.  
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The literature indicates that wide variation in LoS across providers exists. It is expectable to 
find variation in average hospital LoS even when controlling the influence of patients’ 
characteristics. Since this study is based on a method used in a series of articles, which 
concluded that only in some cases hospital characteristics are able to explain differences in 
hospitals’ average LoS, it is expectable to find the same effect. 
 
3. The Choice of the Episodes of Care 
In order to perform the analysis six medical conditions, commonly designated as “episodes of 
care” (EoC) in the literature, were selected.
4
 The choice of the EoC took into account what 
was pointed out by Corallo et al. (2014, p.12): “In studying medical practice variations, it is 
important to focus on conditions and procedures that are clinically important, policy relevant, 
resource intensive (…) and/or have high level of public awareness”. Therefore, the episodes 
of care which represent main causes of hospitalization and/or main causes of death in Portugal 
were investigated. Surgical treatments were privileged over medical conditions, since the 
former seem more important, according to the facts listed below, in terms of policy relevance. 
In Portugal, the main causes of hospitalization among young people are respiratory and 
digestive diseases, whereas among adults are diseases of the circulatory system and cancer 
(Ministério da Saúde, 2011). These diseases also count as the main causes of death. However, 
respiratory diseases stand out as the dominant cause of death (Direcção Geral da Saúde, 
2015). Looking at cardiovascular diseases, in the European Union 28 countries the mortality 
rate for cerebrovascular diseases is higher than that of ischemic heart disease (e.g. acute 
myocardial infarction) (Direcção Geral da Saúde, 2015). Comparing Portugal with the other 
27 European countries, the inverse case is the norm. Portugal is the second European country 
with the lowest mortality rate for ischemic heart disease and its rate for cerebral vascular 
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 An episode of care is “an NHS term of art for a care episode of an inpatient, outpatient, day case, day patient, 
or for haemodialysis. Each episode is initiated by a referral (or re-referral) or admission, and is ended by a 
discharge”(Segen's Medical Dictionary, 2011). 
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accident is above the European Union 28 Member States average (Direcção Geral da Saúde, 
2015). Thus, it is interesting to analyze the LoS of acute myocardial infarction (AMI) since it 
stands out when comparing to the other European countries. Besides it is in the category of 
diseases of the circulatory system. Appendectomy is analyzed since it is a common disease of 
the digestive system and breast cancer surgery is representative of the cancer category. 
Inguinal hernia surgery and cholecystectomy were also chosen as two more examples of 
gastrointestinal diseases. Pneumonia was also included because it is the main cause of 
hospitalization among respiratory diseases (Direcção-Geral de Saúde, 2014).  
The study will analyze the following six episodes of care, namely two medical conditions and 
four surgical treatments, acute myocardial infarction, appendectomy, breast cancer surgery, 




4. Data and Methodology 
The data used is taken from the Diagnostic Related Groups’ data set of Administração Central 
do Sistema de Saúde (ACSS). The year under analysis is 2012 as it is the most recent year 
with available (and not provisional) data. 
Variation in length of stay may be due to patients’ characteristics and needs as well as due to 
other factors such as hospital characteristics. Accordingly, we specify a hierarchical two-stage 
model. In the first stage, the focus will be on the patient-level variables and their ability to 
explain variation in length of stay. The first-stage model includes DRGs’ dummy variables, 
individual characteristics and treatment-specific variables. After the estimation of stage 1, we 
present graphically the average hospital effects for each hospital purged of the influence of 
the patients’ population. Hospitals were ordered from left to right from those with the lowest 
                                                 
5 It would be interesting to analyze the case of coronary artery bypass graft as a further case representing 
circulatory diseases. However, there were few observations (six observations) for the hospital characteristics and 
a minimum number of hospital observations is required to perform the analysis using the selected approach 
(Street, Conrad, Thomas, & Josselin, 2012).  
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mean effects to the highest. This means that patients who were treated in hospitals in the left-
hand side of the graph had a lower LoS compared to the ones more to the right. As a 
consequence, hospitals positioned more to the left are more efficient. The purpose of stage 2 
is to determine whether the identified differences in average length of stay across hospitals 
can be explained by hospital characteristics. The second stage will have as dependent variable 
the estimated hospital effects and will test which hospital characteristics are able to explain 
differences in the average length of stay across providers.
7
 The estimation method procedure 
proposed by Street et al. (2012) is adopted. As mentioned by the authors, their method is “of 
general interest to researchers evaluating variation in [costs or length of stay] among patients 
and across healthcare providers” (Street, Conrad, Thomas, & Josselin, 2012, p. 16).  
As shown by Lu et al. (2015) many studies use the OLS model to predict LoS. However, LoS 
is a count variable, which is normally characterized by its skewed distribution. The adopted 
model in this study is a generalized linear model (a Poisson model or a negative binomial 
model) instead of OLS. In the presence of a skewed dependent variable, the use of an OLS 
model would violate its normality assumption. 
The choice between a Poisson and a negative binomial model will depend on the existence of 
overdispersion (Cameron & Trivedi, 2005). In the presence of overdispersion, a negative 
binomial model is required in order to relax the assumption of “equidispersion” and to avoid 
underestimation of standard errors, which results in overconfidence in the results (namely 
rejecting the null hypothesis when, in fact, it should not be rejected). Dummy variables for 
each hospital were included in the first-stage regression so that the estimation of hospital 
fixed effects was possible. The estimated hospital effects can be interpreted as a “measure of 
relative hospital performance” (Street, Conrad, Thomas, & Josselin, 2012, p. 9).  
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 Hospital fixed effects are an estimated dependent variables and, thus, “suffer both sampling and random errors” 
(Street, Conrad, Thomas, & Josselin, 2012, p. 10). As in Street et al. (2012, p. 10), these sources of errors were 
accounted for by computing a “GLS regression with weights proportional to the inverse of the squared standard 
errors and Efron robust standard errors to correct for potential heteroscedasticity”. 
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Regressions presented and discussed are poisson models in all cases, except in the cases of 
AMI and pneumonia, where negative binomial models are applied, since overdispersion was 
identified in length of stay of these episodes of care.
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Since we focus on six EoC, patients that fall under the EoC in question had to be identified 
either through diagnostics or procedures, depending on the case. With the exception of 
pneumonia, which was not analyzed in the EuroDRG project, the detailed definition of 
eligible patients and the choice of the treatment-specific variables for each EoC can be found 
in the respective EuroDRG project articles.
9
 The definition of pneumonia eligible patients was 
based on Aronsky and Haug (2000): eligible patients were identified by a primary diagnosis 
code of pneumonia or a primary diagnosis of respiratory failure with a secondary diagnosis 
code of pneumonia.  
In all EoC patients aged less than one year are excluded (Street, Conrad, Thomas, & Josselin, 
2012) as well as patients identified in the data set as having an undetermined gender and 
patients attending ambulatory production line “as different classification systems are used to 
describe this activity” (Street, Conrad, Thomas, & Josselin, 2012, p. 8). In addition, hospitals 
with less than 10 eligible patients for the EoC in question were excluded in order to avoid 
inclusion of outlier hospitals. 
Length of stay outliers were dropped from the analysis. As LoS distributions are skewed, 
“only right-tailed length of stay outliers are identified on a log-transformation of LoS with an 
upper trim based on three times the standard deviation threshold” (Street, Conrad, Thomas, & 
Josselin, 2012, p. 9).
10
 
Table 1 summarizes the explanatory variables.  
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 Appendix 1 includes the test for overdispersion for each EoC. 
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 Häkkinen, Chiarello, Cots, Peltola, & Rättö, 2012; Mason, et al., 2012; O' Reilly, Serden, Talback, & 
McCarthy, 2012; Paat-Ahi, Swiderek, Sakowski, Saluse, & Aaviksoo, 2012; Peltola, 2012; Scheller-Kreinsen, 
2012 
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12 
 
Table 1- Explanatory variables 
 Variables’ explanation Abbreviation 
Patient 
variables 
 Diagnosis Related Groups dummy variables 
 Other Diagnosis Related Groups dummy variable 
 Age in quintiles 
 Gender ( =1 if male, =0 if female) 
 Emergency admission dummy variable 
 Transferred in ( =1 if dsp=2, =0 otherwise) 
 Transferred out ( =1 if cause of transference=1 or =2 or  =3 
or =4, =0 otherwise) 
 Number of total diagnostics ( =1, =2 or =3) 
 Number of total procedures ( =0, =1, =2 or =3) 
 No charlson comorbidity ( =1 if patient has no charlson 
comorbidity, =0 otherwise) 
 One non-severe Charlson comorbidity dummy variable  
 At least one severe or two non-severe Charlson comorbidities 
dummy variable 
 Treatment specific dummy variables 
 Deceased ( =1 if the patient died in hospital, =0 otherwise) 
 Urinary tract infection ( =1 if the patient suffered this 
infection during the stay in hospital, =0 otherwise) 
 Postoperative surgical infection ( =1 if the patient suffered 
this infection during the stay in hospital, =0 otherwise) 
 Adverse events dummy variable 
 DRG 1, 2, 3, 4, 5, 6, 7, 8, 9 
 OtherDRGs 













 Defined in Appendix 4 
 Deceased 
 Urinary tract infection 
 
 Postoperative surgical infection 
 
 Adverse events 
Hospital 
variables 
 Number of patients treated annually in thousands 
 The share of the hospital’s patients that fall under the EoC in 
question (in percent) 
 Specialization index 
 Rate per 1000 of infections for all patients of the hospital 
 Rate per 1000 of adverse events for all patients of the 
hospital 
 University hospital dummy variable 
 Totalvol1000 
 EoC percent 
 
 Spec_index 
 Rate infections 
 Rate adverse events 
 
 University hospital 
dsp=2- destination of the patient after discharge: to another institution with internment; cause of the transference =1- to perform medical exams; 
=2- to follow; =3- for lack of resources; =4- for the treatment of an associated condition  
 
In general, the variables were computed as in Street et al. (2012). All patient-level variables 
are dummies. The number of treatment-specific or related comorbidities’ variables depends 
on the EoC in question and ranges from one to six and their choice was based on the articles 
of the second phase of the EuroDRG project. The choice of the treatment-specific variables to 
include in the first-stage pneumonia regression was based on Menéndez, Ferrando, Vallés, 
Martínez, and Perpiña (2001) and Suter-Widmer et al. (2012). To increase the explanatory 
power of the first-stage pneumonia model, frequently used procedures were looked for (i.e., 
injection of antibiotic, injection or infusion of electrolytes or other therapeutic or prophylactic 
substance) and included in the model. Pneumonia-related variables such as fever, blood 
13 
 
pressure and others suggested by the literature (Menéndez, Ferrando, Vallés, Martínez, & 
Perpiña, 2001) could not be included because these were not available in the data set.
11
 
DRGs’ dummy variables were included in the first-stage regression. The DRGs have no 
specific ordering. Only DRGs with at least one percent of the total patients assigned to it were 
singled out by a dummy variable (Street, Conrad, Thomas, & Josselin, 2012). The other 
DRGs represent a range of DRGs that did not fulfill this requisite. Since all patients were 
allocated to one DRG dummy variable, a reference DRG was created. The reference group is 
the one with the highest percentage of patients in that EoC.
12
 
Other variables were incorporated in the first-stage in order to control for demographic 
characteristics. Age categories were built instead of just using one variable capturing age in 
years. Diagnosis-related groups are good predictors of LoS and these include, in some cases, 
specific ages as a split variable (e.g. DRG 772 “Simple Pneumonia and/or Pleurisy, Age <18, 
with complications and comorbidities”). To control for cases where including age is relevant 
for explaining LoS but is not included in any of the DRGs’ dummy variables, the first-stage 
models incorporate age categories. The age categories were “based on quintiles and chosen 
according to the observed distribution of age for the EoC in question” (Street, Conrad, 
Thomas, & Josselin, 2012, p. 12). In all cases, five age categories were defined. The 
justification for including an age reference group is the same as in the DRGs’ dummy 
variables. The reference age category is the one with the highest percentage of patients in that 
EoC. With just two exception (appendectomy and pneumonia), the first age category is the 
reference.
13
 A dummy variable indicates whether the patient was male. 
The impact of the admission type and the destination of the patient after discharge were also 
considered. The variable emergency indicates whether a patient was admitted as an 
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 Appendix 4 includes a summary with the definition of the eligible patients, the treatment-specific variables 
used in each episode of care and the respective International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM) codes used. 
12
 Appendix 5 indicates the number of the DRG used in each DRG dummy variable. 
13
 Appendix 6 shows how the age categories were defined for each episode of care.  
14 
 
emergency. On the one hand, transferred in indicates whether the destination of the patient 
after discharge is to another institution with internment. On the other hand, transferred out 
indicates whether the patient was transferred to another institution by looking at the 
underlying cause of transference. This variable assumes a value equal to one if the patient was 
transferred to perform medical exams, to be followed, because of lack of resources or to treat 
an associated condition. The variable deceased captures the cases in which the patient died 
during hospitalization. 
The total number of diagnosis and procedures by episode was also accounted for. The total 
number of diagnosis ranges from one to three, whereas the total number of procedures ranges 
from zero to three. 
As in Street et al. (2012, p.12), the Charlson comorbidities were divided in three: no Charlson 
comorbidity (the reference), non-severe comorbidity (Myocardial infarction, Congestive heart 
failure, Peripheral vascular Disease, Cerebrovascular disease, Dementia, Chronic pulmonary 
disease, Rheumatic disease, Peptic ulcer disease, Mild liver disease, Diabetes without chronic 
complication, Diabetes with chronic complication) and severe comorbidity 
(“hemiplegia/paraplegia, renal disease, cancer, moderate or severe liver disease, metastatic 
solid tumour and AIDS/HIV”).
 
The variable charlson 1 indicates whether the patient suffers 
from one non-severe Charlson comorbidity. The variable charlson 2 indicates whether the 
patient suffered from at least one severe or two non-severe Charlson comorbidities. It is 
necessary to exclude the Charlson comorbidities whenever they are directly related to the 
EoC. Myocardial infarction is excluded in the case of AMI and cancer and metastic solid 
tumor in the case of breast cancer surgery (Street, Conrad, Thomas, & Josselin, 2012). 
The variables urinary tract infection and postoperative surgical infection indicate whether the 
patient suffered the type of infection in question during hospitalization. Adverse events 
indicate whether “any of the following events occurred: foreign body left in during procedure, 
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infection and inflammatory reaction due to other vascular device, implant, etc., pulmonary 
embolism/deep vein thrombosis, sepsis and accidental cut, puncture, perforation or 
haemorrhage during medical care” (Street, Conrad, Thomas, & Josselin, 2012, p. 12).
 
 
Hospital-level characteristics include “the number of patients treated annually in thousands, 
the share of the hospital’s patients that fall under the health condition in question in percent, a 
specialization index and the both the rate per 1000 of infections [,the reference,] and of 
[adverse events] for all patients of the hospital” (Street, Conrad, Thomas, & Josselin, 2012, p. 
13).
14
 The specialization index was based on Daidone and D’Amico (2009) definition. A 
dummy variable indicates whether the hospital is a university hospital. There are seven 
university hospitals: Santo António, Coimbra, Cova da Beira, São João, São José and Santa 
Maria. Although ownership status is commonly used when referring to hospital 
characteristics, it could not be included since all hospitals that are present in the data set are 
NHS public hospitals. Appendix 7 contains the descriptive statistics of all variables for all 
episodes of care. 
 
5. Results 
Table 2 exhibits an overview of the first-stage results of the six estimated models. Table A 1 
presents the detailed regression results of stage 1 with the coefficients, standard errors and the 
significance level of each variable used. The explanatory power of the models ranges from 
11.9% (pneumonia) to 48.3% (breast cancer surgery). 
Almost every DRG is statistically significant in explaining LoS. The other DRGs are all 
statistically significant and being assigned to one of the other DRGs increases hospital stay. In 
almost every EoC being older (being in the fifth age category) means having a higher length 
of stay when compared to the youngest age category (age category 1). Being a man is just 
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 Following Street et al. approach (p.9) “hospital-level variables have been calculated on the full data set (before 
dropping any outlier)”. 
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statistically significant in two cases (cholecystectomy and inguinal hernia). It increases length 
of stay in the case of cholecystectomy and decreases hospital stay in the case of inguinal 
hernia surgery.   
 
Table 2- Overview of regression results of Stage 1 for all Episodes of Care 







DRGs +/Nsig. +/Nsig. + + -/+/nsig. -/+/Nsig. 
otherDRGs + + + + + + 
Age categories + -/+/Nsig. Nsig. +/Nsig. + -/Nsig. 
Gender Nsig. Nsig. NA + - Nsig. 
Transout Nsig. - Nsig. Nsig. Nsig. - 
Transin - - NA Nsig. NA - 
Totaldiag + + Nsig. + + + 
Totalproc + + + + + + 
Emergency + Nsig. Nsig. + + Nsig. 
Deceased - Nsig. NA Nsig. Nsig. - 
charlson_1 Nsig. Nsig. Nsig. Nsig. Nsig. Nsig. 
Charlson_2 Nsig. Nsig. Nsig. Nsig. Nsig. Nsig. 
Urinary tract infection Nsig. - NA Nsig. Nsig. + 
Postoperative surgical infection NA + NA + + - 
Adverse events Nsig. NA NA NA NA Nsig. 
Treatment specific variables Nsig. Nsig. -/+/Nsig. Nsig. +/Nsig. - 
Comorbidities NA Nsig. NA NA Nsig. -/+/Nsig. 
N 10744 7591 2573 11479 7738 33219 
adjusted Deviance 𝑅2 0.186 0.241 0.461 0.426 0.273 0.119 
Regression model Nbreg poisson poisson Poisson poisson Nbreg 
Note: All regressions used a negative binomial model. + : the variable increases LoS; - : the variable decreases LoS; nsig.: the variable is not 
significant (significance was assessed at the 1% level); NA: not applicable; Nbreg: negative binomial 
 
The variables, which indicate whether a patient was transferred to another institution after 
discharged or transferred to another institution during hospitalization are in the majority of the 
episodes not significant. Patients who were transferred to another institution during 
hospitalization (transout) have a lower LoS in the cases of AMI, appendectomy and 
pneumonia. In the case of appendectomy and pneumonia, patients whose destination after 
discharge was to another institution with internment (transin) also have a lower length of stay. 
The total number of procedures is always statistically significant. The total number of 
diagnosis is also significant for all EoC except for the case of breast cancer surgery. Both a 
higher number of procedures and diagnosis increase LoS. A patient that is admitted as an 
emergency has also a higher length of stay, although it is not statistically significant in three 
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EoC (breast cancer surgery, cholecystectomy and pneumonia). For the cases of appendectomy 
and pneumonia, patients who died whilst in hospital had a lower hospital stay. 
In all EoC analyzed, having one non-severe charlson comorbidity or a severe or two non-
severe charlson comorbidities is not statistically significant. The effect on LoS of having a 
urinary tract infection during hospitalization is mixed. In case of appendectomy it decreases 
length of stay and in the case of pneumonia increases LoS. A postoperative surgical infection 
also yields mixed effects. In three episodes (AMI, cholecystectomy and inguinal hernia 
surgery) it increases the length of stay and in one episode (pneumonia) it decreases hospital 
stay, which is biologically not expectable.
15
 An adverse event is not statistically significant. 
Finally, regarding the treatment specific variables, these are only significant in some cases. In 
the case of AMI they are not statistically significant. Having a laparoscopic surgery 
(appendectomy, cholecystectomy and inguinal hernia surgery) is never statistically 
significant. In the case of appendectomy and inguinal hernia surgery, suffering from essential 
hypertension was not statistically significant. In the case of breast cancer surgery all treatment 
variables are statistically significant, with the exception of plastic operation and total 
mastectomy. When analyzing the case of inguinal hernia surgery, just one treatment variable 
(bilateral inguinal hernia) is statistically significant and increases hospital stay when 
compared to having a unilateral inguinal hernia. Finally, in the case of pneumonia, having a 
principal diagnosis of respiratory failure and pneumonia as a secondary diagnosis decreases 
LoS in comparison to having pneumonia as a principal diagnosis. In this EoC all co-existing 
comorbidities, except chronic pulmonary disease, are statistically significant. Having diabetes 
decreases hospital LoS, which is not expectable. Patients, who suffer from congestive heart 
                                                 
15
 To test whether the unexpected effects are due to the type of model used, the first-stage regression was run 
using OLS (Appendix 8). The OLS gives an intuition for the expected sign of the variables. The OLS regressions 
do not contradict the signs of the negative binomial regressions (with just some exceptions in the appendectomy 
case). Therefore, the unexpected effects are not due to the chosen functional form.  
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failure, have higher hospital stays. Moreover, antibiotic administration, injection or infusion 
of electrolytes or other therapeutic or prophylactic substance decreases LoS. 
Figure 1 shows the variation in average LoS for each EoC across hospitals purged of the 
influence of the variables included in the first-stage. The horizontal line in the graphs 
represents the national average LoS for each episode. Hospitals are ordered from the left to 
the right from the hospitals with the lowest LoS to the ones with the highest. Hospitals with 
wide confidence intervals were excluded.
16
 This happened in two episodes, namely 
cholecystectomy and inguinal hernia. The wide confidence intervals reflect uncertainty 
around the average LoS. This uncertainty arises because a share of patients had long stays, 
which the variables included in the first-stage model did not explain (Gaughan, Mason, Street, 
& Ward, 2012).  
With just the exception of the first left-hand sided hospital in the case of breast cancer surgery 
and the first hospital on the left side of the inguinal hernia surgery graph, the deviation from 
the national average length of stay does not exceed 50%. Pneumonia represents the episode 
with hospitals that diverge less from the national average. In contrast, breast cancer surgery 
and inguinal hernia surgery are the episodes that have many hospitals with lower and higher 
average length of stay when compared to the national average, respectively. Appendix 10 
shows for each episode the ranking of the hospitals. It is not possible to identify a pattern of 
the hospitals that are frequently on the top or bottom of the ranking.  
Table 3 reports the results of stage 2. The second stage regressions show that hospital 
characteristics are not able to explain differences in average LoS. However, in the case of 
appendectomy, the rate of adverse events for all patients in the hospital is statistically 
significant at a 1% level. When compared to the rate of infection, the rate of adverse events 
decreases average length of stay. Therefore, the unexplained variation in average hospital 
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length of stay may be attributed to various reasons: hospital inefficiency, hospitals’ policy, 
physicians’ practices or patient-level characteristics, which were not included in the first-stage 
model. 
 







Figure 1- Average hospital effect for all episodes of care after excluding hospitals with wide confidence 
intervals 
 
Table 3- Regression Results of Stage 2 for all Episodes of Care before removing the outliers 







University hospital -0.063 (0.113) -0.015 (0.036) 0.161 (0.152) -0.064 (0.053) -0.044 (0.125) -0.008 (0.047) 
totvol1000  -0.001 (0.001) -0.000 (0.001) -0.003 (0.002) -0.000 (0.001) -0.000 (0.001) -0.001 (0.000) 
EoC percent -0.021 (0.019) -0.008 (0.108) -0.059 (0.168) -0.013 (0.018) -0.017 (0.038) -0.002 (0.009) 
spec_index -0.286 (0.380) -0.187 (0.280) -0.325 (0.638) -0.277 (0.396) 0.117 (0.479) 0.090 (0.170) 
Rate infections Ref Ref Ref Ref Ref Ref 
Rate adverse events -0.110 (0.234) 0.360** (0.117) 0.165 (0.445) -0.043 (0.222) -0.075 (0.536) -0.083 (0.114) 
_cons -0.247 (0.220) 0.852*** (0.206) 1.129** (0.390) 0.688* (0.260) 0.366 (0.363) 1.345*** (0.126) 
N 38 40 36 42 41 41 
adjusted 𝑅2 0.107 0.121 0.237 0.074 0.085 0.168 
Efron robust standard errors are presented in parentheses. Ref: reference category 
* p<0.05, ** p<0.01, ***p<0.001 
 
5.1. Best practice average length of stay 
Table 4 identifies the best practice average length of stay, i.e. the average length of stay that 
would be desirable if all hospitals would have an average length of stay equal to that of the 
benchmark hospitals. The best practice average length of stay for each episode is based on the 
average length of stay of the top 10% hospitals. The percentage reduction in average length of 
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stay ranges from 11,21% (pneumonia) to 47,65% (breast cancer surgery). With the 
implementation of a best practice average length of stay for each episode, a reduction in the 
total number of hospital days would be possible. Consequently less resources would be used, 
savings in costs would potentially occur and more patients could be treated. 
 














Decrease in the total 
number of hospital 
days per 100 patients 
AMI 5.22 0.68 3.56 -31.71% -165 
Appendectomy 2.92 0.74 2.17 -25.51% -74 
Breast cancer surgery 2.59 0.52 1.36 -47.65% -123 
Cholecystectomy 3.01 0.75 2.27 -24.66% -74 
Inguinal hernia surgery 1.93 0.95 1.32 -31.52% -61 
pneumonia 6.55  0.89 5.82 -11.21% -73 
Note: Best practice average LoS= national average LoS*[1-(1-average fixed effects of the top 10% hospitals)] 
 
Table 5 reports the estimated savings in terms of average hospital days for each episode of 
care. The reduction in the total average number of days ranges from 3174 (breast cancer 
surgery) to 24408 (pneumonia). The highest reduction in average hospital days would be 
possible in the case of AMI, namely a reduction of 1.65 days.  
 
  
Table 5- estimated reduction in average number of days with the reduction of inpatient average hospital days  







Total number of 
hospital days in 2012 
10744 7591 2573 13105 7738 33219 
reduction in average 
hospital days 
1.653597 0.744352 1.233857 0.74265 0.609626 0.734767 
reduction in the total 
number of hospital 
days with reduced 
inpatient average LoS 
17766.25 5650.376 3174.714 9732.428 4717.286 24408.22 
Note: reduction in the total number of hospital days with reduced inpatient average LoS= Total number of hospital days in 2012* 
reduction of average hospital days 
 
6. Conclusions 
This study focused on medical practice variation by analyzing average length of stay across 
Portuguese NHS hospitals for the year of 2012. The aim of this work was to find out (1) 
whether average length of stay across Portuguese NHS hospitals varies much when adjusting 
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for patients’ case mix; (2) whether hospital characteristics explain the differences in average 
hospital stay and (3) what the average length of stay would be if all hospitals would have an 
average length of stay equal to that of the benchmark hospitals. It analyzed six different 
episodes of care, namely AMI, appendectomy, breast cancer surgery, cholecystectomy, 
inguinal hernia surgery and pneumonia.  
The results are in line with previous studies. From the results, it is clear that a high proportion 
of the variation is not due to the fact that different hospitals serve different populations 
(patients’ characteristics explained between 11% - pneumonia- and 46% -breast cancer 
surgery- of length of stay). When adjusting for differences in patients’ characteristics, average 
length of stay across hospitals varies not more than 50% when compared to the national 
average. Regarding the explanations for the differences in average length of stay, the results 
show that hospital-level characteristics are not able to explain these differences. With just the 
exception of appendectomy, the rate of adverse events for all patients in the hospital is 
statistically significant at a 1% level. Therefore, the explanation for the differences in average 
length of stay across Portuguese NHS hospitals may be due to hospitals’ inefficiency, 
hospitals’ policies, physicians’ practices or patient-level characteristics which were not 
included in the models.  
The study shows that some hospitals could improve their performance. If a best practice LoS 
was implemented by looking at the LoS of the top 10% hospitals for each EoC, a decrease of 
11% to 46% in average length of stay could be achieved. This would mean a saving in the 
total average number of hospital days. For instance, a reduction of 3174 average days in the 
case of breast cancer surgery and 24408 average days in the case of pneumonia. This would 
potentially imply savings in terms of costs and the treatment of more patients. 
One limitation of this study is related to the patient-level characteristics. It was not possible to 
control for sociodemographic variables because these are not available in the data set. 
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Including this type of explanatory variables as well as more measures of health status could 
increase the explanatory power of the first-stage model. Therefore, ACSS should collect more 
information to incorporate in the DRGs’ data set so that researchers were able to take these 
aspects into account when analyzing medical practice variation.  
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Table A 1- Regression Results of Stage 1 for all Episodes of Care 
Stage1 AMI Appendectomy 
Breast Cancer 
Surgery 
Cholecystectomy Inguinal Hernia Surgery Pneumonia 
DRG1 1.195*** (0.019) 1.440*** (0.020) 1.089** (0.032) 1.533*** (0.079) 1.088* (0.039) 1.242*** (0.021) 
DRG2 Ref 1.193*** (0.044) Ref 1.436*** (0.065) 1.175*** (0.027) 1.151*** (0.034) 
DRG3 1.013 (0.084) Ref 
  
1.338*** (0.027) Ref Ref 
DRG4 1.106 (0.061) 0.953    (0.090) 
  
Ref 0.701*** (0.036) 0.924*** (0.008) 
DRG5 1.217*** (0.031)   
  
1.692*** (0.066)   1.323*** (0.031) 
DRG6 0.980 (0.017) 
      
  1.059*** (0.007) 
DRG7 0.975 (0.016) 
      
  0.745*** (0.017) 
DRG8           0.722*** (0.015) 
DRG9           1.010 (0.043) 
otherDRGs 1.340*** (0.041) 1.348*** (0.053) 1.275*** (0.077) 2.204*** (0.096) 1.370*** (0.067) 1.230*** (0.029) 
agecat1 Ref 1.113*** (0.017) Ref Ref Ref 0.938*** (0.009) 
agecat2  1.050**    (0.016) Ref 1.003 (0.020) 1.036* (0.017) 1.051** (0.019) Ref 
agecat3 1.159*** (0.019) 0.955** (0.015) 1.020 (0.021) 1.065*** (0.017) 1.101*** (0.020) 0.996 (0.008) 
agecat4 1.240*** (0.021) 1.024 (0.016) 1.030 (0.023) 1.154*** (0.020) 1.104*** (0.021) 1.003 (0.008) 
agecat5 1.230*** (0.023) 1.145*** (0.018) 1.020 (0.023) 1.299*** (0.022) 1.207*** (0.023) 0.992 (0.009) 
Gender 0.988 (0.012) 1.006 (0.010) 
  
1.029*** (0.011) 0.948** (0.018) 0.999 (0.006) 
Transout 0.799* (0.076) 0.696*** (0.024) 1.055 (0.052) 0.541 (0.243) 0.500 (0.231) 0.860** (0.046) 
Transin 0.752** (0.069) 0.318*** (0.042) 
  
1.154 (0.466)   0.603*** (0.033) 
Totaldiag 1.207*** (0.025) 1.034*** (0.009) 1.014 (0.009) 1.030*** (0.008) 1.037*** (0.010) 1.141*** (0.011) 
Totalproc 1.531*** (0.068) 1.040*** (0.009) 1.074*** (0.015) 1.141*** (0.010) 1.064*** (0.009) 1.106*** (0.011) 
emergency  1.266*** (0.025) 1.102* (0.048) 0.899 (0.086) 1.571*** (0.022) 1.197*** (0.026) 1.007 (0.017) 
Deceased 0.511*** (0.036) 0.498* (0.167) 
  
0.793* (0.081) 0.794 (0.334) 0.595*** (0.006) 
charlson_1 1.034* (0.014) 1.014 (0.025) 1.020 (0.021) 0.972 (0.015) 0.956* (0.018) 1.000 (0.007) 
charlson_2 1.071* (0.035) 1.117 (0.093) 1.106 (0.102) 0.991 (0.041) 0.964 (0.047) 1.005 (0.009) 
Urinary tract infection 1.091 (0.055) 0.636** (0.096) 
  
1.049 (0.213) 1.421* (0.247) 1.053*** (0.014) 
Postoperative surgical infection 
  





Stage1 AMI Appendectomy 
Breast Cancer 
Surgery 
Cholecystectomy Inguinal Hernia Surgery Pneumonia 
Adverse events 1.484 (0.844) 
      
  1.117 (0.327) 
ST-elevated MI 1.057 (0.040) 
      
    
Non-ST elevated MI 1.066 (0.040) 
      
    
Subsequent MI 0.898 (0.068) 
      
    
Unspecified AMI Ref 
      
    
Laparoscopy  1.040 (0.097)   0.906* (0.039) 0.927 (0.054)   
maindiagnosis_carcinomabreast 
    
0.916*** (0.024) 
  
    
secondarydiag_maligneoplasm 
    
1.221*** (0.048) 
  
    
Partialexcision_mammarygland     Ref       
Lympnode resection 
    
1.120** (0.041) 
  
    
Plastic operation 
    
1.015 (0.064) 
  
    
Total mastectomy 
    
1.113 (0.129) 
  
    
Essential hypertension   1.005 (0.024)     0.998 (0.016)   
Unilateral IH         Ref   
Bilateral IH         1.127*** (0.018)   
Implants         0.999 (0.015)   
pneumonia           Ref 
Respiratory failure           0.683*** (0.022) 
diabetes            0.969*** (0.009) 
Chronic pulmonary disease           0.964 (0.023) 
Congestive heart failure           1.035*** (0.010) 
Antibiotic           0.961*** (0.007) 
Injection or infusion of electrolytes           0.931*** (0.007) 
Injection or Infusion NEC           0.919*** (0.010) 
N 10744 7591 2573 11479 7738 33219 
Intercept 0.123*** (0.005) 2.285*** (0.125) 2.854*** (0.162) 1.610*** (0.089) 1.388*** (0.075) 3.884*** (0.192) 
adjusted Deviance 𝑅2 0.186 0.241 0.461 0.426 0.273 0.119 
Regression model Negative binomial poisson poisson poisson Poisson Negative binomial 
Note: The coefficients are exponentiated. Robust standard errors are presented in parentheses. Ref: reference category 
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Appendix 1- test for overdispersion 
 likelihood ratio test of alpha=0 Model 
AMI Alpha=0.0798124 chibar2(01) =  637.01 Prob>=chibar2 = 0 Negative Binomial 
Appendectomy Alpha=1.23e-27 chibar2(01) = 0.00 Prob>=chibar2 = 1 Poisson 
Breast Cancer Surgery Alpha=1.33e-14 chibar2(01) =    0.00 Prob>=chibar2 = 1 Poisson 
Cholecystectomy Alpha= 7.60e-08 chibar2(01) = 0.0e+00 Prob>=chibar2 = 0 Poisson 
Inguinal Hernia 
Surgery 
Alpha=2.47e-12 chibar2(01) = 0.00 Prob>=chibar2 = 1 Poisson 
Pneumonia Alpha=0.092959 chibar2(01) = 3268.11 Prob>chibar2 = 0 Negative Binomial 
 
Appendix 2 A- Length of stay distribution (before dropping any outlier) for all Episodes of care 









Appendix 2B- Length of stay distribution (before dropping any outlier) for each episode of care 
 Skewness Kurtosis 
AMI 6.590868 90.63245 
Appendectomy 4.620844 44.26898 
Breast Cancer Surgery 4.292982 52.10421 
Cholecystectomy 6.563344 75.92096 
Inguinal Hernia Surgery 5.041982 10.16667 
Pneumonia 19.17504 970.8536 
Note: If the coefficient of skewness is negative, the distribution is 
skewed left. If the coefficient is positive, skewed right. As a 
benchmark, the normal distribution has a coefficient of kurtosis 
of 3. 
 
Appendix 3- Calculation of the outliers 
 Standard deviation of logarithm LoS 3 times standard deviation of logarithm LoS Outliers 
AMI 0.856638 2.569914 LoS>13 
Appendectomy 0.6231127 1.869338 LoS>6 
Breast cancer Surgery 0.596584 1.789751 LoS>5 
Cholecystectomy 0.800111 2.400333 LoS>11 
Inguinal Hernia Surgery 0.613834 1.841502 LoS>6 





Appendix 4- definition and explanation of first-stage level variables and ICD-9-CM codes used in the analysis 
 Defined by ICD-9-CM code exclude Additional information 
Urinary tract infection diagnosis 599.0   
Postoperative surgical infection Diagnosis 998.59   
Adverse events diagnosis 








AMI: Treatment-specific variables 
ST-elevated Myocardial Infarction diagnosis 410.0x-410.6x and  410.8x if the fifth digit is 2 Abbr.:  ST-elevated MI 
non-ST-elevated Myocardial Infarction Diagnosis 410.7x if the fifth digit is 2 Abbr.:  non-ST-elevated MI 
subsequent Myocardial Infarction diagnosis 410.x2  Abbr.:  subsequent MI 
Unspecified AMI Diagnosis 410.9x if the fifth digit is 2 Used as the reference group 
PTCA procedure 00.66  No observations 
Appendectomy 
Eligible patients 






(essential) hypertension  401.9   
Appendectomy: treatment-specific variables 
laparoscopy procedure 47.01   
Breast cancer surgery 
Eligible patients 
Main Diagnosis and 
procedure 
Diangosis: 174-174.9 or 233.0 
Procedure: 85.20-85.23 or 85.33-
85.36, 85.4  
Male patients  
Breast cancer surgery: treatment-specific variables 
main diagnosis “carcinoma in situ of 
breast” 
Diagnosis 233.0  Abbr.: maindiagnosis_carcinomabreast 
Secondary diagnosis of “malignant 
neoplasm of female breast” 
Diagnosis 174  
No observations 
Abbr.:secondarydiag_maligneoplasm 
Secondary and unspecified malignant 
neoplasm of lymph nodes  
Diagnosis 196  
No observations 
Abbr.:secondaryunspecified_lymphnodes 
secondary diagnosis related to metastases diagnosis 196.1-196.9  Abbr.: secondarydiagnosis_metastases 
lymph node resection Procedure 0.3-40.5, 85.43-85.48   





 Defined by ICD-9-CM code exclude Additional information 
Total mastectomy Procedure 85.33-85.36, 85.4   
Cholecystectomy 
Eligible patients 





Cholecystectomy: treatment-specific variables 
Laparoscopy Procedure 51.23   
Inguinal hernia surgery 
Eligible patients 
Main Diagnosis and 
procedure 
Diagnosis: 550-550.93; 
procedure: 17.1- 17.13, 17.2-
17.22, 53.0-53.17 
  
Inguinal hernia surgery: comorbidities 
Essential hypertension  401.9   
Connective tissue disorders  710.9  No observations 
Inguinal hernia surgery: treatment-specific variables 
Unilateral Inguinal Hernia Diagnosis 550.90, 550.91  Used as the reference group 
Bilateral inguinal hernia Diagnosis 550.92, 550.93   
Unspecified inguinal hernia Diagnosis 550, 550.0, 550.1, 550.9  No observations 
laparoscopy procedure 17.1-17.24   
implants Diagnosis 





Main or main and 
secondary diagnosis 
Pneumonia: 480-482.83, 482.89- 
486 
Respiratory failure:  518.8, 
518.82 
 Pneumonia is the reference group 
Pneumonia: comorbidities     
Diabetes  250.00-250.93   
Chronic pulmonary disease  490, 491, 492, 494, 496   
Congestive heart failure  428.0   
Pneumonia: treatment-specific variables 
Antibiotic Procedure 99.21   
Injection Or Infusion Of Electrolytes Procedure 99.18   
Injection or infusion NEC (of other 
therapeutic or prophylactic substance ) 




Appendix 5- All Patient Diagnosis-Related Groups (version 21) used in the DRGs’ dummies 
 AMI Appendectomy Breast Cancer Surgery Cholecystectomy Inguinal Hernia Surgery Pneumonia 
DRG1 121 165 259 197 160 79 
DRG2 122 166 260 198 161 80 
DRG3 123 167  493 162 89 
DRG4 144 883  494 163 90 
DRG5 550   556  540 
DRG6 808     541 
DRG7 853     772 
DRG8      773 
DRG9      882 
Other DRGs 
105, 106, 107, 108, 109, 
110, 111, 112, 115, 116, 
119, 120, 124, 125, 145, 
468, 470, 477, 478, 479, 
543, 545, 546, 547, 548, 
549, 795, 796, 804, 849, 
852, 854, 878 
148, 149, 150, 151, 
153, 155, 158, 164, 
170, 171, 468, 553 
257, 258, 265, 266, 564 
191, 192, 193, 194, 
196, 555, 787 
148, 149, 151, 157, 158, 
159, 166, 167, 553, 554, 
585 
75, 76, 77, 87, 99, 
100, 468, 470, 477, 
538, 539, 631, 700, 
701, 704, 705, 706, 
707, 708, 710, 712, 
713, 714, 740, 770, 
771, 877, 878, 881 
 
Appendix 6- Definition of the age categories for each Episode of care 
Age category AMI Appendectomy Breast Cancer Surgery Cholecystectomy Inguinal Hernia Surgery Pneumonia 
Agecat1 20-55 2-12 17-47 6-40 1-51 1-62 
Agecat2 56-65 13-19 48-55 41-52 51-61 63-76 
Agecat3 66-73 20-28 56-62 53-61 62-69 77-82 
Agecat4 74-81 29-42 63-68 62-71 70-76 83-87 









Appendix 7- Descriptive Statistics: patient variables and hospital variables for all Episodes of Care 
 
AMI Appendectomy Breast Cancer Surgery Cholecystectomy Inguinal Hernia Surgery Pneumonia 
No. Patients 10744 7591 2573 11479 7738 33219 
No. Hospitals 38 40 36 42 41 41 
Patients variables Mean (Std. Dev.) 
LoS 5.21 (3.14) 2.92 (1.37) 2.59 (1.14) 3.01 (2.10) 1.93 (1.09) 6.55 (3.46) 
Age 67.88 (13.94) 27.9 (17.83) 58.24 (11.72) 56.76 (16.05) 62.27 (19.36) 71.63 (22.98) 
Totaldiag 2.91 (0.35) 1.43 (0.72) 2.31 (0.84) 2.19 (0.88) 2.02 (0.91) 2.85 (0.45) 
Totalproc 2.95 (0.25) 2.6 (0.72) 2.72 (0.57) 2.41 (0.84) 2.09 (0.93) 2.92 (0.37) 
 Percentage of pacients (%) 
DRG1 17.26 11.63 13.02 1.71 2.69 2.56 
DRG2 29.72 1.71 84.88 7.27 9.59 1.06 
DRG3 6.21 56.26 
  
8.78 84.22 47.31 
DRG4 1.29 28.65 
  
78.72 1.74 13.62 
DRG5 4.72  
  
2.20    1.28 
DRG6 15.80 
      
  23.69 
DRG7 19.95 
      
  1.84 
DRG8          4.02 
DRG9          1.02 
otherDRGs 5.05 1.74 2.10 1.32 1.73 3.59 
Gender 66.23 54.78 0 34.34 90 52.05 
Transin 14.29 2.16 0 0.16 0.05 2.83 
Transout 19.27 5.74 18.93 4.51 5.71 8.79 
emergency  91.10 98.59 1.01 18.53 10.34 96.69 
Deceased 8.59 0.09 0 0.25 0.05 21.74 
charlson_0 74.14 95.77 88.73 84.18 85.67 53.89 
charlson_1 22.31 3.99 11.04 14.25 12.73 33.40 
charlson_2 3.55 0.24 0.23 1.57 1.60 12.71 
Urinary tract infection 0.83 0.07 0 0.05 0.03 4.02 
Postoperative surgical infection 0 0.12 0 0.13 0.03 0.00003 
Adverse events 0.02 0 0 0 0 0.02 
ST-elevated MI 44.49 
      
    
Non-ST elevated MI 50.95 
      
    
Subsequent MI 1.12 
      





 AMI Appendectomy Breast Cancer Surgery Cholecystectomy Inguinal Hernia Surgery Pneumonia 
Unspecified AMI 3.44 
      
    
PTCA  0 
      
    







    
8.7 
  
    
secondarydiag_maligneoplasm 
    
0 
  
    
secondaryunspecified_lymphnodes 
    
0 
  
    
secondarydiagnosis_metastases 
    
7.00 
  
    
Partialexcision_mammarygland     99.53       
Lympnode resection 
    
3.34 
  
    
Plastic operation 
    
0.66 
  
    
Total mastectomy 
    
0.47 
  
    
Essential hypertension   4.83     26.03   
Connective tissue disorders         0   
Unilateral IH         79.98   
Bilateral IH         13.41   
Other IH         0   
Implants         73.42   
pneumonia           97.19 
Respiratory failure           2.81 
diabetes            9.90 
Chronic pulmonary disease           1.13 
Congestive heart failure           9.27 
Antibiotic           25.20 
Injection or infusion of electrolytes           11.12 
Injection or infusion NEC           3.55 
hospital variables Percentage of patients (%) 
University hospital 7.89 7.50 8.33 7.14 7.32 7.32 
 Mean (Std. Dev.) 
totvol1000  40.74 (31.76) 41.8 (33.6) 44.53 (35.99) 42.88 (36.27) 40.61 (33.57) 43.7 (36.46) 
EoC percent 1.4 (2.31) 0.91 (1.5) 0.32 (0.44) 1.5 (2.96) 1.97 (3.92) 4.89 (9.74) 
spec_index 0.61 (0.08) 0.61 (0.08) 0.62 (0.12) 0.62 (0.11) 0.61 (0.09) 0.62 (0.11) 
Rate infections 8.70 (4.78) 8.64 (4.67) 7.93 (4.5) 8.27 (4.88) 8.46 (4.79) 8.16 (4.57) 
Rate adverse events 0.11 (0.11) 0.11 (0.11) 0.12 (0.11) 0.11 (0.1) 0.11 (0.1) 0.12 (0.10) 
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Appendix 8- OLS Regression Results of Stage 1 for all Episodes of Care 
Stage1 AMI Appendectomy 
Breast Cancer 
Surgery 
Cholecystectomy Inguinal Hernia Surgery Pneumonia 
DRG1 1.014*** (0.083) 0.255*** (0.016) 0.218** (0.072) 1.295*** (0.200) 0.180** (0.068) 1.430*** (0.117) 
DRG2 Ref 0.173*** (0.039) Ref 0.700*** (0.172) 1.175*** (0.042) 0.867*** (0.177) 
DRG3 0.265 (0.216) Ref 
  
0.921*** (0.058) Ref Ref 
DRG4 0.556* (0.253) 0.120    (0.091) 
  
Ref -0.556*** (0.089) -0.537*** (0.056) 
DRG5 1.351*** (0.137)   
  
1.998*** (0.119)   1.856*** (0.153) 
DRG6 -0.114 (0.091) 
      
  0.384*** (0.044) 
DRG7 -0.165 (0.087) 
      
  -1.739*** (0.137) 
DRG8           -1.798*** (0.116) 
DRG9           0.226 (0.177) 
otherDRGs 1.522*** (0.143) 0.215*** (0.043) 0.651*** (0.134) 3.324*** (0.161) 0.777*** (0.085) 1.204*** (0.126) 
agecat1 Ref 0.0261*** (0.015) Ref Ref Ref -0.463*** (0.059) 
agecat2  0.240**    (0.080) Ref 0.0109 (0.053) 0.0980* (0.048) 0.0840* (0.035) Ref 
agecat3 0.724*** (0.085) 0.00451** (0.015) 0.0585 (0.054) 0.160*** (0.048) 0.173*** (0.035) -0.0147*** (0.053) 
agecat4 1.111*** (0.085) 0.0329* (0.015) 0.0765 (0.056) 0.392*** (0.05) 0.177*** (0.036) 0.0376 (0.054) 
agecat5 1.087*** (0.093) 0.108*** (0.017) 0.0533 (0.056) 0.850*** (0.051) 0.373*** (0.037) -0.0289 (0.055) 
Gender -0.0713 (0.058) -0.00460 (0.009) 
  
0.0802* (0.032) -0.108** (0.036) -0.0106 (0.035) 
Transout -0.641 (0.367) -0.309 (0.417) 0.0700 (0.876) -3.516** (1.209) -1.327** (0.478) -0.764** (0.247) 
Transin -1.562*** (0.361) 0.189 (0.419) 
  
1.639 (1.143)   -2.750*** (0.240) 
Totaldiag 0.692*** (0.079) 0.0171 (0.009) 0.0378 (0.024) 0.0812*** (0.022) 0.0667*** (0.018) 0.717*** (0.050) 
Totalproc 1.314*** (0.112) 0.00479 (0.008) 0.181*** (0.035) 0.332*** (0.024) 0.125*** (0.016) 0.568*** (0.057) 
emergency  0.842*** (0.105) -0.131** (0.042) -0.245 (0.171) 1.688*** (0.042) 0.392*** (0.037) 0.0506 (0.104) 
Deceased -3.169*** (0.183) -0.103 (0.163) 
  
-0.935** (0.308) -0.434 (0.478) -3.093*** (0.045) 
charlson_1 0.186** (0.065) -0.0210 (0.026) 0.0549 (0.057) -0.0766 (0.047) -0.0905* (0.036) -0.00536 (0.044) 
charlson_2 0.301* (0.143) 0.0554 (0.101) 0.313 (0.353) -0.00312 (0.126) -0.0841 (0.091) 0.0548 (0.055) 
Urinary tract infection 0.607* (0.289) -0.118 (0.19) 
  
0.396 (0.660) 1.517* (0.674) 0.329*** (0.088) 
Postoperative surgical infection 
  
0.390** (0.141)   2.926*** (0.419) 1.816** (0.677) -2.896 (3.086) 
Adverse events 1.888 (1.898) 
      
  0.489 (1.381) 
ST-elevated MI 0.268 (0.159) 
      
    
Non-ST elevated MI 0.322* (0.158) 
      
    
Subsequent MI -0.764* (0.303) 
      
    
Unspecified AMI Ref 
      





Stage1 AMI Appendectomy 
Breast Cancer 
Surgery 
Cholecystectomy Inguinal Hernia Surgery Pneumonia 
Laparoscopy  -0.00314 (0.090)   -1.078* (0.163) -0.131 (0.130)   
maindiagnosis_carcinomabreast 
    
-0.201** (0.063) 
  
    
secondarydiag_maligneoplasm 
    
0.573*** (0.093) 
  
    
Partialexcision_mammarygland     Ref       
Lympnode resection 
    
0.376*** (0.107) 
  
    
Plastic operation 
    
0.0471 (0.212) 
  
    
Total mastectomy 
    
0.455 (0.283) 
  
    
Essential hypertension   -0.0444 (0.026)     -0.00361 (0.030)   
Unilateral IH         Ref   
Bilateral IH         0.249*** (0.033)   
Implants         -0.00416 (0.028)   
pneumonia           Ref 
Respiratory failure           -2.014*** (0.140) 
diabetes            -0.200** (0.063) 
Chronic pulmonary disease           -0.219 (0.163) 
Congestive heart failure           0.213** (0.066) 
Antibiotic           -0.252*** (0.043) 
Injection or infusion of electrolytes           -0.377*** (0.059) 
Injection or Infusion NEC           -0.465*** (0.095) 
N 10744 7591 2573 11479 7738 33219 
Intercept -2.014*** (0.398) 1.183*** (0.051) 1.872*** (0.203) 2.290*** (0.186) 1.454*** (0.066) 3.849*** (0.243) 
adjusted 𝑅2 0.273 0.079 0.447 0.414 0.242 0.206 
Standard errors are presented in parentheses. Ref: reference category 





Appendix 9- Average hospital effect for all Episodes of Care before excluding hospitals with wide confidence intervals 
  
 
Appendix 10- hospitals’ ranking 
 
AMI appendecetomy Breast cancer surgery cholecystectomy Inguinal hernia surgery pneumonia 
Rank Hospital_id 
1 CHGE EVOR IPOL CASC CHDV CHGE 
2 CHAL ULSL LOUR EVOR CASC MATO 
3 CHUC CHSJ IPOP PREL AMAD IPOL 
4 CHSE ULSG CHVS ULSL XIRA CHPO 
5 ULAM CHSE BRAG BARC LOUR XIRA 
6 SANT ULBA CASC CHLP EVOR EVOR 
7 XIRA BRAG BARC LOUR CHVS FIGU 
8 CASC ULCB CHSE CHDV BARC CHMT 
9 CHLP BARC SANT XIRA BRAG CHUC 
10 CHTV CHGE ULAM CHAA CHMA CHSE 
11 EVOR CHAL CHGE CHSJ ULAM CHO 
12 ULNA XIRA CHLO CHVS CHAA CHTV 
13 CHLO CHLC CHSJ BRAG CHSJ  CHDV 





 AMI appendecetomy Breast cancer surgery cholecystectomy Inguinal hernia surgery pneumonia 
rank Hospital_id 
15 ULSN CHVS CHAA CHGE CHGE ULAM 
16 CHLC CHBM MATO FIGU CHTA CHAA 
17 ALMA PVVC CHLC CHCB CHLP BARC 
18 MATO CHLP CHTA MATO ULSL CBVG 
19 CHBM ULAM CHPO AMAD CHSE CHLP 
20 ULCB AMAD EVOR IPOL CHCB CHLC 
21 CHPO CHTV ULSL ULAM CHUC AMAD 
22 BRAG LOUR ULNA CHMA CHMT ULSL 
23 CHMA CASC CHDV CHUC FIGU CHVS 
24 CHDV CHLO PVVC CHLC ULBA CHMA 
25 ULSL CHMT CHAL CHSE CHO CASC 
26 CHAA CHAA CHLN CHTA ULSG BRAG 
27 CHCB CHCB AMAD CHTV PVVC SANT 
28 CBVG FIGU ULBA CBVG MATO ALMA 
29 CHO CBVG CHBM CHO CHTV LOUR 
30 ULBA MATO CHMA ALMA CHPO ULCB 
31 CHTA CHO CHUC CHBM OVAR CHBM 
32 CHVS CHDV IPOC ULBA CBVG CHAL 
33 CHSJ ULNA CHCB PVVC CHBM CHLO 
34 CHMT CHTA CHTV CHMT CHLC ULNA 
35 AMAD CHPO XIRA ULCB CHAL CHCB 
36 CHLN ULSN ALMA CHLO CHLO ULBA 
37 ULSG CHMA 
 
OVAR ULCB CHLN 
38 PVVC ALMA 
 










SANT ULSN CHTA 
41 
   
CHAL ULNA IPOP 
42 
   
ULNA 
  
 
